Move Free Glucosamine
TINA.org, along with AARP, objected — as amici curiae — to a class-action settlement that sought to resolve claims filed against Schiff Nutrition for deceptively marketing Move Free® Advanced glucosamine…
Move Free®
November 2015: After the settlement in the Lerma case was approved in October 2015, this lawsuit was dismissed When a complaint is dismissed with prejudice, it cannot be refiled..
November 2014: The parties in the lawsuit asked the court to suspend the judicial proceedings in the case because Schiff Nutrition reached a settlement agreement in another similar case (Lerma v. Schiff), and that settlement, if approved, would also settle the claims in this case.
December 2013: A class-action lawsuit was filed against Schiff Nutrition for allegedly advertising its Move Free® line of dietary supplements containing glucosamine and chondroitin as providing various joint health benefits – such as helping to protect cartilage and improving joint comfort and function – without the scientific evidence to support such claims.
To learn more about the Lerma case, click here. (Flowers et al. v. Schiff Nutrition, Schiff Nutrition International, Inc., Schiff Nutrition Group, Inc., Reckitt Benckiser Pharmaceuticals, Inc. and Reckitt Benckiser North America, Inc., Case No. 13-cv-09406, C.D. CA.).
For more information about other class-action lawsuits filed against Schiff Nutrition International and TINA.org’s coverage of the company, click here.
Legal Action
Class-Action Tracker
Move Free Glucosamine Supplements
Allegations: Falsely advertising that Move Free provides joint health benefits when the ingredients in the supplement do not provide such benefits
Schiff Move Free® Advanced
May 2016: The appeal was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.. The reasons have not been disclosed. November 2015: A federal judge granted…
Move Free® Supplements
August 2016: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled. because the claims were resolved pursuant to a settlement in another case, Lerma…
The Latest
CATrends: OTC Cold and Flu Meds Falsely Marketed as Nasal Decongestants
An FDA panel’s recent findings has led to a flood of lawsuits.
Researchers Call on FDA (Again) to Remove ‘Ineffective’ OTC Cold and Flu Medicines
Products marketed to clear up stuffy noses and relieve sinus congestion don’t work, researchers say.
Proposed Settlement Allows for Continued Deceptive Marketing of Neuriva
TINA.org files brief urging court to deny final approval of settlement that is unfair to consumers.
CATrends: Toddler Formula
It’s the perfect formula for a class-action lawsuit trend.
